BioSante Pharma (BPAX) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts BPAX Hot Sheet
Join SI Premium – FREE
BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) reported Q1 loss of $0.20, $0.06 worse than the analyst estimate of ($0.14).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- JD.com earnings preview: stronger profit expected, macro headwinds in focus
- ITG (ITG) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
